Leaflet DEFLOXOL 90mg film-coated tablets

Product code:
W68592001
Quantity:
30
Indicated for:
iron overload
Route of administration:
oral
Substance:
deferasirox (chelating agent)
ATC
V03AC03 — Various | All other therapeutic products | All other therapeutic products | Iron chelating agents
Deferasirox is an iron chelator used for the treatment of chronic iron overload in patients with frequent blood transfusions, such as those with major thalassemia. It works by binding excess iron, facilitating its elimination through feces.

The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.

Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.

This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.

General data about DEFLOXOL 90mg

Substance:
deferasirox
Date of latest medicines list:
01-04-2022
Product code:
W68592001
Concentration:
90mg
Pharmaceutical form:
film-coated tablets
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
PHARAMATHEN INTERNATIONAL S.A. - GRECIA
Holder:
EGIS PARMACEUTICALS PLC - UNGARIA
Number:
14307/2022/01
Shelf life:
3 years

Pharmaceutical forms available for deferasirox

Concentrations available for deferasirox

  • 125mg
  • 180mg
  • 250mg
  • 360mg
  • 500mg
  • 90mg